Although the complicated roles of GLRX3 in cancer remain poorly understood, overexpression of GLRX3 was ascertained in several types of malignancy, such as nasopharyngeal carcinoma (NPC), oral squamous cell carcinoma (OSCC), colon cancer, and lung cancer25–27. Here, GLRX3 is linked to nasopharyngeal carcinoma.